logo
Select company
Select metric
$ -5.58MConsolidated Income
VS
Market
39
Sector
74
Industry
88
History
96
$ 1.05Close
$ 0.75 - $ 1.97 52-Week Range
Ticker Information

Ticker

DYAI

Company Name

DYADIC INTERNATIONAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DYADIC INTERNATIONAL INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DYAI - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -5.58M
3/31/2025$ -5.83M
12/31/2024$ -5.81M
9/30/2024$ -6.33M
6/30/2024$ -7.74M
3/31/2024$ -7.85M
12/31/2023$ -6.8M
9/30/2023$ -6.87M
6/30/2023$ -7.07M
3/31/2023$ -8.2M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DYADIC INTERNATIONAL INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -9.1M.
  • Over the past 5 years, DYADIC INTERNATIONAL INC's average Cons. Inc. has been $ -8.89M.
  • The median Cons. Inc. for DYADIC INTERNATIONAL INC during this period was $ -8.65M
  • DYADIC INTERNATIONAL INC reached its highest Cons. Inc. over the past 5 years at $ -5.58M.
  • The lowest Cons. Inc. recorded by DYADIC INTERNATIONAL INC in the same timeframe $ -13.07M

DYADIC INTERNATIONAL INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
CAMP : CAMP4 THERAPEUTICS CORP $ -51.78MNRXS : NEURAXIS INC $ -7.17MLPCN : LIPOCINE INC $ -4.51MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MSTTK : SHATTUCK LABS INC $ -61.51MCLSD : CLEARSIDE BIOMEDICAL INC $ -27.71MMRKR : MARKER THERAPEUTICS INC $ -14.61MIGC : IGC PHARMA INC $ -6.34MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.56MALGS : ALIGOS THERAPEUTICS INC $ -74.18M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

DYAI - Consolidated Income, Last 5 years

$ -13.07M

Minimum

Dec 31, 2021

$ -5.58M

Maximum

Jun 30, 2025

$ -8.89M

Average

$ -8.65M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M